Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Balance (in shares) at Dec. 31, 2019   5,795      
Beginning balance at Dec. 31, 2019 $ 6,797 $ 6 $ 190,019 $ 50 $ (183,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,534)       (2,534)
Issuance of common stock under:          
Matching contribution to 401(k) plan (in shares)   26      
Matching contribution to 401(k) plan 155   155    
In lieu of cash compensation (in shares)   9      
In lieu of cash compensation 50   50    
Shares issued as a result of rounding due to reverse-stock split (in shares)   13      
Stock-based compensation expense 587   587    
Foreign currency translation adjustments 173     173  
Balance (in shares) at Mar. 31, 2020   5,843      
Ending balance at Mar. 31, 2020 5,228 $ 6 190,811 223 (185,812)
Balance (in shares) at Dec. 31, 2019   5,795      
Beginning balance at Dec. 31, 2019 6,797 $ 6 190,019 50 (183,278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (14,301)        
Issuance of common stock under:          
Matching contribution to 401(k) plan (in shares)   26      
Matching contribution to 401(k) plan     155    
Balance (in shares) at Jun. 30, 2020   7,814      
Ending balance at Jun. 30, 2020 (28) $ 8 197,513 30 (197,579)
Balance (in shares) at Mar. 31, 2020   5,843      
Beginning balance at Mar. 31, 2020 5,228 $ 6 190,811 223 (185,812)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (11,767)       (11,767)
Issuance of common stock under:          
Equity financing, net (in shares)   1,748      
Equity financing, net 7,082 $ 2 7,080    
Exercise of warrants (in shares)   223      
Exercise of warrants 1,436 $ 0 1,436    
Issuance of warrants (2,322)   (2,322)    
Stock-based compensation expense 508   508    
Foreign currency translation adjustments (193)     (193)  
Balance (in shares) at Jun. 30, 2020   7,814      
Ending balance at Jun. 30, 2020 (28) $ 8 197,513 30 (197,579)
Balance (in shares) at Dec. 31, 2020   8,349      
Beginning balance at Dec. 31, 2020 4,434 $ 8 204,376 (847) (199,103)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (3,670)       (3,670)
Issuance of common stock under:          
Equity financing, net (in shares)   3,980      
Equity financing, net 35,360 $ 4 35,356    
Exercise of warrants (in shares)   300      
Exercise of warrants 3,878 $ 1 3,877    
Matching contribution to 401(k) plan (in shares)   26      
Matching contribution to 401(k) plan 152        
Stock-based compensation expense 356   356    
Foreign currency translation adjustments 465     465  
Balance (in shares) at Mar. 31, 2021   12,655      
Ending balance at Mar. 31, 2021 40,975 $ 13 244,117 (382) (202,773)
Balance (in shares) at Dec. 31, 2020   8,349      
Beginning balance at Dec. 31, 2020 4,434 $ 8 204,376 (847) (199,103)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (4,943)        
Issuance of common stock under:          
Matching contribution to 401(k) plan     152    
Balance (in shares) at Jun. 30, 2021   12,655      
Ending balance at Jun. 30, 2021 40,096 $ 13 244,636 (507) (204,046)
Balance (in shares) at Mar. 31, 2021   12,655      
Beginning balance at Mar. 31, 2021 40,975 $ 13 244,117 (382) (202,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,273)       (1,273)
Issuance of common stock under:          
Stock-based compensation expense 519   519    
Foreign currency translation adjustments (125)     (125)  
Balance (in shares) at Jun. 30, 2021   12,655      
Ending balance at Jun. 30, 2021 $ 40,096 $ 13 $ 244,636 $ (507) $ (204,046)